Diabetes

BUFFALO, N.Y. — Tops Markets, which operates 132 stores in western New York and Pennsylvania, is offering customers a new service to help them make healthier eating choices and develop better habits, according to a report by The Buffalo News.

BOSTON — Scientists at the Harvard School of Public Health and collaborators from other institutions have identified a natural substance in dairy fat that substantially may reduce the risk of Type 2 diabetes. 

Reporting in the Dec. 21 issue of the Annals of Internal Medicine, investigators led by Dariush Mozaffarian, associate professor in the Department of Epidemiology at HSPH, explained that the compound trans-palmitoleic acid is a fatty acid found in milk, cheese, yogurt and butter that is not produced by the body.

DEERFIELD, Ill., and OSAKA, Japan — Takeda and its subsidiary settled the patent suits it brought against generic drug makers that sought to develop their own versions of its diabetes treatment.

PRINCETON, N.J. — A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

Emisphere will be paid $57.5 million in potential product development and sales milestone payments by Novo Nordisk — of which $5 million dollars will be payable upon signing — as well as royalties on sales. Further financial details of the agreement were not disclosed.

MADISON, N.J. — Nearly one-third of pregnant women are not being screened by a laboratory test for gestational diabetes mellitus (gestational diabetes), according to a study of more than 900,000 American women published online Tuesday on the Obstetrics and Gynecology site.

SAN DIEGO — Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.

WASHINGTON — More than 6% of women who gave birth in hospitals in the United States in 2008 had diabetes or developed gestational diabetes during pregnancy, according to a new analysis by the federal government's Agency for Healthcare Research and Quality.

NEW YORK — A link may exist between diabetes and the use of inhaled corticosteroids to treat asthma and chronic obstructive pulmonary disease, according to published reports.

HealthDay News reported that researchers analyzed data on 380,000 patients in Quebec, finding a 34% increase in the rate of new diagnoses of diabetes and progression of the disease among those who used inhalers, with greater risk among those using higher doses.